Business Description
2seventy bio Inc
NAICS : 325412
SIC : 2834
Compare
Compare
Traded in other countries / regions
TSVT.MexicoTSVT.USA IPO Date
2021-10-18Description
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.99 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.87 | |||||
| Debt-to-EBITDA | -1.08 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -0.5 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.5 | |||||
| 3-Year EBITDA Growth Rate | 20.4 | |||||
| 3-Year EPS without NRI Growth Rate | 19.7 | |||||
| 3-Year FCF Growth Rate | 14.1 | |||||
| 3-Year Book Growth Rate | 63.4 | |||||
| Future 3-5Y Total Revenue Growth Rate | 11.96 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.99 | |||||
| 9-Day RSI | 52.07 | |||||
| 14-Day RSI | 46.71 | |||||
| 6-1 Month Momentum % | -7.29 | |||||
| 12-1 Month Momentum % | -20.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.77 | |||||
| Quick Ratio | 3.77 | |||||
| Cash Ratio | 3.34 | |||||
| Days Sales Outstanding | 63.1 | |||||
| Days Payable | 115.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.7 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.34 | |||||
| Operating Margin % | -287.34 | |||||
| Net Margin % | -277.77 | |||||
| ROE % | -69.83 | |||||
| ROA % | -33.76 | |||||
| ROIC % | -57.99 | |||||
| ROC (Joel Greenblatt) % | -86.64 | |||||
| ROCE % | -39.82 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.02 | |||||
| PB Ratio | 1.25 | |||||
| Price-to-Tangible-Book | 1.33 | |||||
| EV-to-EBIT | -1.91 | |||||
| EV-to-EBITDA | -1.99 | |||||
| EV-to-Forward-EBITDA | -2.23 | |||||
| EV-to-Revenue | 5.48 | |||||
| EV-to-Forward-Revenue | 3.82 | |||||
| EV-to-FCF | -1.92 | |||||
| Earnings Yield (Greenblatt) % | -52.36 |
How 2seventy bio Inc (TSVT) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TSVT
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
2seventy bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 91.496 | ||
| EPS (TTM) ($) | -7.44 | ||
| Beta | 0 | ||
| Volatility % | 73.27 | ||
| 14-Day RSI | 46.71 | ||
| 14-Day ATR ($) | 0.635037 | ||
| 20-Day SMA ($) | 10.033 | ||
| 12-1 Month Momentum % | -20.93 | ||
| 52-Week Range ($) | 8.44 - 19.33 | ||
| Shares Outstanding (Mil) | 50.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
2seventy bio Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
2seventy bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
2seventy bio Inc Frequently Asked Questions
What is 2seventy bio Inc(TSVT)'s stock price today?
The current price of TSVT is $10.20. The 52 week high of TSVT is $19.33 and 52 week low is $8.44.
When is next earnings date of 2seventy bio Inc(TSVT)?
The next earnings date of 2seventy bio Inc(TSVT) is 2023-05-12 Est..
Does 2seventy bio Inc(TSVT) pay dividends? If so, how much?
2seventy bio Inc(TSVT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
